HomeAKRO • NASDAQ
add
Akero Therapeutics Inc
Previous close
$18.93
Day range
$18.95 - $19.97
Year range
$11.25 - $58.38
Market cap
1.35B USD
Avg Volume
1.07M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 61.87M | 143.40% |
Net income | -55.19M | -139.33% |
Net profit margin | — | — |
Earnings per share | -0.99 | -102.04% |
EBITDA | -61.87M | -143.49% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 550.01M | 56.50% |
Total assets | 580.27M | 62.74% |
Total liabilities | 44.96M | 49.84% |
Total equity | 535.31M | — |
Shares outstanding | 56.30M | — |
Price to book | 1.97 | — |
Return on assets | -25.45% | — |
Return on capital | -26.43% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -55.19M | -139.33% |
Cash from operations | -48.63M | -90.63% |
Cash from investing | 12.79M | 112.60% |
Cash from financing | 502.00K | -81.56% |
Net change in cash | -35.34M | 71.55% |
Free cash flow | -28.95M | -60.73% |
About
Founded
2017
Headquarters
Website
Employees
55